Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome
Graphical AbstractIC50 = 11 nM (PI3Kδ); 244 nM (PI3Kα); 424 nM (PI3Kβ), 2,230 nM (PI3Kγ).
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2024-02-01
|
| Serija: | Frontiers in Pharmacology |
| Teme: | |
| Online pristup: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1337436/full |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|